Monthly Archives: February 2017

Gonzaga Changes Name and Enters into Goldenville Acquisition Agreement

VANCOUVER, BC / ACCESSWIRE / February 24, 2017 / OSPREY GOLD DEVELOPMENT LTD. (TSX-V: OS) (the “Company” or “Osprey”) is pleased to announce it has completed its previously announced name change from Gonzaga Resources Ltd. to Osprey Gold Development Ltd. It is anticipated that the Company’s common shares will commence trading on the TSX Venture Exchange under the new symbol “OS” upon the opening of the markets on Monday, February 27, 2017. The CUSIP number assigned to the Company’s shares following the name change is 688401108 (ISIN: CA6884011082). No action is required to be taken by shareholders with respect to the name change. Outstanding share certificates are not affected by the name change and do not need to be exchanged.

The Company also announced that it has entered into a definitive acquisition agreement (the “Acquisition Agreement”) with Crosby Gold Ltd. (“Crosby”) in connection with the previously disclosed acquisition (the “Acquisition”) of an option to acquire a 100% interest in the Goldenville Gold Project located in Guysborough County, Nova Scotia (the “Goldenville Property”). As disclosed in the Company’s January 10, 2017 news release, pursuant to an option agreement dated October 14, 2016 (the “Option Agreement”), Crosby holds an option to acquire a 100% interest (subject to certain royalties) in the Goldenville Property.

Under the terms of the Acquisition Agreement, the Company will acquire all of the issued and outstanding shares of Crosby (the “Crosby Shares”) in consideration for the issuance of common shares of the Company on the basis of common share for each Crosby Share, resulting in the issuance of an aggregate of 5,840,000 common shares of the Company to Crosby’s shareholders. Upon completion of the Acquisition, Crosby will be a wholly owned subsidiary of the Company. For additional details regarding the Goldenville Property, the Option Agreement and the Acquisition, please refer to the Company’s January 10, 2017 news release.

Completion of the Acquisition is subject to a number of conditions including, completion by the Company of an equity financing for minimum aggregate proceeds of $500,000, execution of final transaction documentation and receipt of TSX Venture Exchange approval.

ON BEHALF OF OSPREY GOLD DEVELOPMENT LTD.

“Cooper Quinn”
Cooper Quinn, President

For further information please contact Osprey at (236)521-0944

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

All statements in this press release, other than statements of historical fact, are “forward-looking information” with respect to Osprey within the meaning of applicable securities laws, including statements with respect to the proposed acquisition of the Goldenville Property option and the transactions contemplated in connection therewith. Osprey provides forward-looking statements for the purpose of conveying information about current expectations and plans relating to the future and readers are cautioned that such statements may not be appropriate for other purposes. By its nature, this information is subject to inherent risks and uncertainties that may be general or specific and which give rise to the possibility that expectations, forecasts, predictions, projections or conclusions will not prove to be accurate, that assumptions may not be correct and that objectives, strategic goals and priorities will not be achieved. These risks and uncertainties include but are not limited to those identified and reported in Osprey’s public filings under Osprey’s SEDAR profile at www.sedar.com. Although Osprey has attempted to identify important factors that could cause actual actions, events or results to differ materially from those described in forward-looking information, there may be other factors that cause actions, events or results not to be as anticipated, estimated or intended. There can be no assurance that such information will prove to be accurate as actual results and future events could differ materially from those anticipated in such statements. Osprey disclaims any intention or obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise unless required by law.

UNITED STATES ADVISORY. The securities referred to herein have not been and will not be registered under the United States Securities Act of 1933, as amended (the “U.S. Securities Act”), have been offered and sold outside the United States to eligible investors pursuant to Regulation S promulgated under the U.S. Securities Act, and may not be offered, sold, or resold in the United States or to, or for the account of or benefit of, a U.S. Person (as such term is defined in Regulation S under the United States Securities Act) unless the securities are registered under the U.S. Securities Act, or an exemption from the registration requirements of the U.S. Securities Act is available. Hedging transactions involving the securities must not be conducted unless in accordance with the U.S. Securities Act. This press release shall not constitute an offer to sell or the solicitation of an offer to buy any securities, nor shall there be any sale of securities in the state in the United States in which such offer, solicitation or sale would be unlawful.

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. ANY FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF U.S. SECURITIES LAWS.

SOURCE: Osprey Gold Development Ltd.

ReleaseID: 455977

Maca Extract Market by Type, Product, Application, Region and Forecast to 2022

ReportsWeb.com added “Global Maca Extract Market Research Report 2017” to its vast collection of research Database. The report is spread across 111 pages and supported by 17 company leaders.

February 24, 2017 /MarketersMedia/

The Global Maca Extract Market Research Report 2017 is a professional and in-depth study on the current state of the Maca Extract industry. In a word, This report studies Maca Extract in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with capacity, production, price, revenue and market share for each manufacturer. Key companies included in this research are Koken, Peruvian Nature, ZANACEUTICA, INCA HEALTH, Pebani, StandPeru, Phyto Life Sciences, Jiaherb, Pioneer Herbs, Green Life, Yuansn Biological, Bettering, Yongyuan Bio-Tech, Naturalin, Berbchem Biotech, Tengmai and Huike.

Browse complete report @ http://www.reportsweb.com/global-maca-extract-market-research-report-2017

Market Segment by Region, this report splits Global into several key Region, with sales, revenue, market share and growth rate of Maca Extract in these regions, from 2011 to 2022 (forecast), like North America, Europe, China, Japan, Southeast Asia and India. Firstly, Maca Extract Market On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into White to Yellow, Light Pink to Dark Purple and Light Gray to Dark Gray. On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales) , market share and growth rate of Maca Extract for each application, including Health Drugs, Healthy Foods and Nutritional Supplements.

Request for Sample @ http://www.reportsweb.com/inquiry&RW0001637102/sample

Major points from Table of Contents:

1 Maca Extract Market Overview

2 Global Maca Extract Market Competition by Manufacturers

3 Global Maca Extract Production, Revenue (Value) by Region (2011-2017)

4 Global Maca Extract Supply (Production) , Consumption, Export, Import by Regions (2011-2017)

5 Global Maca Extract Production, Revenue (Value) , Price Trend by Type

6 Global Maca Extract Market Analysis by Application

7 Global Maca Extract Manufacturers Profiles/Analysis

7.1 Koken
7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.1.2 Maca Extract Product Category, Application and Specification
7.1.2.1 Product A
7.1.2.2 Product B
7.1.3 Koken Maca Extract Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.1.4 Main Business/Business Overview
7.2 Peruvian Nature
7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.2.2 Maca Extract Product Category, Application and Specification
7.2.2.1 Product A
7.2.2.2 Product B
7.2.3 Peruvian Nature Maca Extract Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.2.4 Main Business/Business Overview
7.3 ZANACEUTICA
7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.3.2 Maca Extract Product Category, Application and Specification
7.3.2.1 Product A
7.3.2.2 Product B
7.3.3 ZANACEUTICA Maca Extract Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.3.4 Main Business/Business Overview

8 Maca Extract Manufacturing Cost Analysis

9 Industrial Chain, Sourcing Strategy and Downstream Buyers

10 Marketing Strategy Analysis, Distributors/Traders

11 Market Effect Factors Analysis

12 Global Maca Extract Market Forecast (2017-2022)

13 Research Findings and Conclusion

List of Tables and Figures

Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Maca Extract
Figure Manufacturing Process Analysis of Maca Extract
Figure Maca Extract Industrial Chain Analysis
Table Raw Materials Sources of Maca Extract Major Manufacturers in 2016
Table Major Buyers of Maca Extract
Table Distributors/Traders List
Figure Global Maca Extract Capacity, Production and Growth Rate Forecast (2017-2022)
Figure Global Maca Extract Revenue and Growth Rate Forecast (2017-2022)
Figure Global Maca Extract Price and Trend Forecast (2017-2022)
Table Global Maca Extract Production Forecast by Region (2017-2022)
Figure Global Maca Extract Production Market Share Forecast by Region (2017-2022)
Table Global Maca Extract Consumption Forecast by Region (2017-2022)
Figure Global Maca Extract Consumption Market Share Forecast by Region (2017-2022)
Figure North America Maca Extract Production and Growth Rate Forecast (2017-2022)
Figure North America Maca Extract Revenue and Growth Rate Forecast (2017-2022)
Table North America Maca Extract Production, Consumption, Export and Import Forecast (2017-2022)
Figure Europe Maca Extract Production and Growth Rate Forecast (2017-2022)
Figure Europe Maca Extract Revenue and Growth Rate Forecast (2017-2022)
Table Europe Maca Extract Production, Consumption, Export and Import Forecast (2017-2022)
Figure China Maca Extract Production and Growth Rate Forecast (2017-2022)
Figure China Maca Extract Revenue and Growth Rate Forecast (2017-2022)
Table China Maca Extract Production, Consumption, Export and Import Forecast (2017-2022)
Figure Japan Maca Extract Production and Growth Rate Forecast (2017-2022)
Figure Japan Maca Extract Revenue and Growth Rate Forecast (2017-2022)
Table Japan Maca Extract Production, Consumption, Export and Import Forecast (2017-2022)
Figure Southeast Asia Maca Extract Production and Growth Rate Forecast (2017-2022)
Figure Southeast Asia Maca Extract Revenue and Growth Rate Forecast (2017-2022)
Table Southeast Asia Maca Extract Production, Consumption, Export and Import Forecast (2017-2022)
Figure India Maca Extract Production and Growth Rate Forecast (2017-2022)
Figure India Maca Extract Revenue and Growth Rate Forecast (2017-2022)
Table India Maca Extract Production, Consumption, Export and Import Forecast (2017-2022)

Place a Direct Purchase Order of Complete Report @ http://www.reportsweb.com/buy&RW0001637102/buy/2900

Contact Info:
Name: Sameer Joshi
Email: sales@reportsweb.com
Organization: ReportsWeb
Address: Pune, India.
Phone: +1-646-491-9876

Source URL: http://marketersmedia.com/maca-extract-market-by-type-product-application-region-and-forecast-to-2022/172853

For more information, please visit http://www.reportsweb.com/global-maca-extract-market-research-report-2017

Source: MarketersMedia

Release ID: 172853

SHAREHOLDER UPDATE: Brodsky & Smith, LLC Announces an Investigation of The Board of Directors of LMI Aerospace, Inc. – LMIA

BALA CYNWYD, PA / ACCESSWIRE / February 24, 2017 / Law office of Brodsky & Smith, LLC announces that it is investigating potential claims against the Board of Directors of LMI Aerospace, Inc. (“LMI Aerospace” or “the Company”) (NASDAQ: LMIA – News) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to Sonaca Group. (“Sonaca”).

Click here to learn more: http://www.brodskysmith.com/cases/lmi-aerospace-inc-nasdaq-lmia/, or call: 877-534-2590. There is no cost or obligation to you.

Under the terms of the transaction, LMI Aerospace common shareholders will receive only $14.00 in cash for each share of LMI Aerospace stock they own. The investigation concerns whether the Board of LMI Aerospace breached their fiduciary duties to shareholders and whether Sonaca is underpaying for the Company. The transaction may undervalue the Company and would result in a loss or no real gain for many LMI Aerospace shareholders. For example, shares of LMI Aerospace stock traded at $14.29 per share on March 4, 2015. In addition, the transaction contains various deal protections that may prevent a better offer from being received by LMI Aerospace.

If you own shares of LMI Aerospace stock and wish to discuss the legal ramifications of the investigation, or have any questions, you may e-mail or call the law office of Brodsky & Smith, LLC who will, without obligation or cost to you, attempt to answer your questions. You may contact Jason L. Brodsky, Esquire or Evan J. Smith, Esquire at Brodsky & Smith, LLC, Two Bala Plaza, Suite 510, Bala Cynwyd, PA 19004, by visiting http://www.brodskysmith.com/cases/lmi-aerospace-inc-nasdaq-lmia/, or calling toll free 877-LEGAL-90.

Brodsky & Smith, LLC is a litigation law firm with extensive expertise representing shareholders throughout the nation in securities and class action lawsuits. The attorneys at Brodsky & Smith have been appointed by numerous courts throughout the country to serve as lead counsel in class actions and have successfully recovered millions of dollars for our clients and shareholders. Attorney advertising. Prior results do not guarantee a similar outcome.

SOURCE: Brodsky & Smith, LLC

ReleaseID: 455958

Abattis Completes Audit and Prepares to Launch Northern Vine Labs

VANCOUVER, BC / ACCESSWIRE / February 24, 2017 / Abattis Bioceuticals Corp. (OTCQB: ATTBF) (CNSX: ATT) (“ATT” or the “Company”) is pleased to announce the completion of their annual audit. The delay in filing was due to an eventful year with new programs coming online and an aggressive strategy to cut non-core assets resulting in prolonged consolidations and subsequent review.

Management has been focusing their efforts on their Northern Vine Lab buildout after receiving their controlled substance dealers license (“CSL”) in 2016. The lab setup has been expedited and is now approximately 45 days away from opening its doors to licensed producer and MMAR patient customers for cannabis testing and analytics. Issues surrounding quality control and massive cannabis product recalls from licensed producers by Health Canada have recently taken headlines in the press. Northern Vine Labs is strategically positioned in Langley, British Columbia and holds a considerable geographic advantage over their few competitors as the region has many MMAR growers looking to prove their products’ quality.

Northern Vine Labs has the necessary licenses and controls in place to legally possess and work with the raw herb (cannabis) and its active ingredients. The company will provide analytical R&D and quality control testing on a large variety of cannabis based products, screening for cannabinoids, terpenes, microbiological contaminants, pesticides and residual solvents. The license also allows Northern Vine to formulate new products for licensed producers in Canada.

Updates: Since last week’s release, Abattis, through its subsidiary Vergence Bioceuticals, delivered their first order, consisting of three pallets of Green Nature’s dried berry products, to Sunrype. Although modest in size, this marks the beginning of Green Nature’s sales cycle in what looks to be a busy year filled with trade shows and selling.

Lastly, negotiations with Raybot Science Co. and Abattis China Co. (a wholly owned subsidiary of Abattis) have been progressing well and Abattis will soon be testing Raybot’s patented extraction methods in Canada. Raybot claims that its technology will allow for pure isolate derivatives of the Cannabis plant to be extracted at a fraction of the cost and in one seamless process as opposed to the 2-3 step extraction methods of CO2. Abattis continues to perform due diligence on this opportunity and will keep investors updated on their progress.

About Abattis Bioceuticals Corp.

Abattis is a specialty agricultural technology and biotechnology company which aggregates, integrates, and invests in agricultural technologies and biotechnology services for the legal cannabis industry developing in Canada. The Company has successfully developed and licensed natural health products, medicines, extractions, and ingredients for the biologics, nutraceutical, bioceutical, and cosmetic markets. The Company also is also seeking to acquire exclusive intellectual property rights to agricultural technologies to be employed in extraction and processing of botanical ingredients and compounds. The Company follows strict standard operating protocols, and adheres to the applicable laws of Canada and foreign jurisdictions. For more information, visit the Company’s website at: www.abattis.com.

About Northern Vine Canada Inc.

Northern Vine Labs™ is licensed by Health Canada for the possession of Cannabis and related active ingredients, as well as the production of extracts for the purposes of analysis. Northern Vine Labs™ product certification and quality assurances programs incorporate global best practices and procedures for application in the Canadian market.

About Vergence Visionary Bioceuticals Corp.

Vergence Visionary Bioceuticals, dba Vergence Sales and Marketing Group, is a wholly owned subsidiary of Abattis Bioceuticals Corp. based in Vancouver, B.C., Canada. The Vergence team are bioceutical marketing specialists focused on health products to penetrate the fast-growing market for natural, safe and effective natural products that meet unmet wellness needs.

About Green Nature Health Care Products

Green Nature Health Care Products Inc. (http://www.green-nature.ca/en/) was established in 2012 by Jasmine Guan. The main market is the local travelers and immigrants, wholesalers. Over 400 customers have been obtained in China since the end of 2012 on dried blueberry and cranberry dried products, including the Wal-Mart chain supermarket and more than 200 to import and export food-based industry chain supermarkets. Green Nature has customs clearance through six cities in China: Shanghai, Nantong, Qingdao, Tianjin, Guangzhou, Hong Kong.

“Rene David”
Rene David, CFO/COO

For further information, contact the Company at (604) 336-0881 or at news@abattis.com.

NEITHER THE CANADIAN SECURITIES EXCHANGE NOR ITS REGULATIONS SERVICES PROVIDER HAVE REVIEWED OR ACCEPT RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.

SOURCE: Abattis Bioceuticals Corp.

ReleaseID: 455975

Desert Gold Announces Extension of Its Non-Brokered Private Placement

SURREY, BC / ACCESSWIRE / February 24, 2017 / Desert Gold Ventures Inc. (TSX-V: DAU) (FSE: QXR2) (OTC PINK: DAUGF) (“Desert Gold” or “the Company”) announces that it has received consent from the Toronto Venture Stock Exchange (“TSX-V”) to extend the closing of its non-brokered private placement, initially announced November 22, 2016 to March 10, 2017. The financing consists of up to 4,000,000 units at a price of CAD$0.25 per unit (the “Unit”) to raise up to an aggregate CAD$1,000,000 (the “Financing”).

Each Unit will consist of one common share in the equity of the Company and one share purchase warrant (the “Warrant”). Each Warrant shall entitle the holder to purchase one additional common share of the Company at a price of CAD$0.30 per share for a period of five (5) years from the closing of this Financing. Warrants will be subject to a thirty (30) day acceleration upon announcement by the Company that its shares have traded on a weighted average of $1.00 per common share, or more, for ten (10) consecutive trading days.

The proceeds of the Financing will be used for general working capital and development purposes. There may be a finder’s fee payable for the Financing. Securities issued as a result of the Financing will be subject to a statutory hold period. The Financing is subject to the TSX-V approval.

ON BEHALF OF THE BOARD

“Jared Scharf”
Jared Scharf
Director and President
(604) 245-6802

For further information, please visit our website www.desertgold.ca, or find information available on www.SEDAR.com under the company’s profile.

Certain statements contained in this release may constitute “forward-looking statements” or “forward-looking information” (collectively “forward-looking information”) as those terms are used in the Private Securities Litigation Reform Act of 1995 and similar Canadian laws. These statements relate to future events or future performance. The use of any of the words “could,” “intend,” “expect,” “believe,” “will,” “projected,” “estimated,” “anticipates,” and similar expressions and statements relating to matters that are not historical facts are intended to identify forward-looking information and are based on the Company’s current belief or assumptions as to the outcome and timing of such future events. Actual future results may differ materially. In particular, this release contains forward-looking information relating to the business of the Company, the Property, financing and certain corporate changes. The forward-looking information contained in this release is made as of the date hereof and the Company is not obligated to update or revise any forward-looking information, whether as a result of new information, future events, or otherwise, except as required by applicable securities laws. Because of the risks, uncertainties, and assumptions contained herein, investors should not place undue reliance on forward-looking information. The foregoing statements expressly qualify any forward-looking information contained herein.

Neither the TSX Venture Exchange nor its regulation services provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

This news release does not constitute an offer to sell or a solicitation of an offer to buy the securities described herein in the united states. The securities described herein have not been and will not be registered under the united states securities act of 1933, as amended, and may not be offered or sold in the united states or to the account or benefit of a U.S. person absent an exemption from the registration requirements of such act.

SOURCE: Desert Gold Ventures Inc.

ReleaseID: 455973

Centurion Closes Over-subscribed Private Placement

VANCOUVER, BC / ACCESSWIRE / February 24, 2017 / Centurion Minerals Ltd. (TSX-V: CTN) (“Centurion,” “the Company”) is pleased to announce that it has closed a second tranche of a non-brokered private placement and issued 3,692,143 Units priced at $0.07 for proceeds of $258,450. The Company previously announced a first tranche closing of $321,000 and subsequently increased the total funds to be raised from $350,000 to $579,000. Each Unit consists of one common share and one warrant. Each warrant will be exercisable for one common share at $0.12 during the first year or $0.15 during the second year, following the closing. Finders fees of $8,347 and 113,250 broker warrants (having the same terms as the subscribers) have been paid. The shares are subject to a four month hold period expiring in June, 2017.

Proceeds from this financing shall be used to advance the Ana Sofia, Argentina agri-gypsum plant, and for general corporate purposes.

ABOUT CENTURION

Centurion Minerals Ltd. is a Canadian-based company with an international focus on the exploration and development of gold and agri-mineral projects.

On Behalf of the Board,

“David G. Tafel”
President and CEO

For Further Information:

David Tafel
Director
604-683-1991

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

This news release contains forward-looking statements concerning future operations of Centurion Minerals Ltd. (the “Company”). All forward-looking statements concerning the Company’s future plans and operations, including management’s assessment of the Company’s project expectations or beliefs may be subject to certain assumptions, risks, and uncertainties beyond the Company’s control. Investors are cautioned that any such statements are not guarantees of future performance and that actual performance and exploration and financial results may differ materially from any estimates or projections. Such statements include, among others: possible variations in mineralization, grade, or recovery rates; actual results of current exploration activities; actual results of reclamation activities; conclusions of future economic evaluations; changes in project parameters as plans continue to be refined; failure of equipment or processes to operate as anticipated; accidents and other risks of the mining industry; delays and other risks related to construction activities and operations; timing and receipt of regulatory approvals of operations; the ability of the Company and other relevant parties to satisfy regulatory requirements; the availability of financing for proposed transactions, programs and working capital requirements on reasonable terms; the ability of thirdparty service providers to deliver services on reasonable terms and in a timely manner; market conditions and general business, economic, competitive, political, and social conditions. It is important to note that the information provided in this news release is preliminary in nature.

SOURCE: Centurion Minerals Ltd.

ReleaseID: 455972

Printed Yoga Pants Release Changes The Face Of Yoga Clothing

Elektrix Love reviews its promise that its printed yoga pants would change things in the Yoga clothing space for the better. Further information can be found at elektrixlove.com.

Printed Yoga Pants Release Changes The Face Of Yoga Clothing

Los Angeles, United States – February 24, 2017 /PressCable/

Elektrix Love has reviewed the Yoga clothing world since it announced the launch of their Printed Yoga Pants back in 2015. Elektrix Love’s printed yoga pants promised to shake things up and two years later, the facts are in.

Previously, with even a passing glance, a person would notice that almost all the available yoga pants are boring colors or patterns. The Founder at Elektrix Love, Katie, makes a point of saying “we knew things were always going to change when we launched our edgy Printed Yoga Pants”.

Katie continues… “Where you’ll likely always see our competitors doing the same old thing, we wanted to continue to produce unique, high-quality yoga clothing. We do this because we believe we believe yogis come from all walks of life and everyone deserves the ability to express themselves.. Ultimately, we knew it was going to be of huge benefit to our customers because now women can express their true style all the time.. We actually hope others follow suit.”

Elektrix Love was established in 2015. It has been doing business for two years and it has always aimed to produce high-quality designs for the rebellious, free spirited girl who thrives on adventure. The pieces and one of a kind prints not only mirror the rebellious spirit but also blend functionality, fit, and street chic into a finely curated collection of activewear.

Currently, the closest thing to Printed Yoga Pants is yoga leggings with “normal,” mainstream patterns, but Elektrix Love improved on this by designing a product line that allows edgy women to express themselves on and off the practice floor. This alone was enough to make Elektrix Love’s patterned yoga pants more popular with customers in the Yoga clothing space, very quickly.

Printed Yoga Pants are now available to buy and review at Amazon.com. To find out more, the place to visit is https://www.amazon.com/Eco-Friendly-Yoga-Pants-Bre…

For further information about Elektrix Love, this can be discovered at elektrixlove.com

Contact Info:
Name: Katie Tomasetta
Organization: Elektrix Love
Address: Downtown, Los Angeles, CA 90031, United States

For more information, please visit https://www.amazon.com/Eco-Friendly-Yoga-Pants-Breathable-Athletic/dp/B01MXIOIXW

Source: PressCable

Release ID: 173008

Plaintree Systems Inc. Announces Fiscal 2017 Third Quarter Results

OTTAWA, ON / ACCESSWIRE / February 24, 2017 / Plaintree Systems Inc. (Plaintree, traded on CNSX under the symbol NPT).

Q3 2017 Results

Plaintree announced today that it has released its un-audited condensed consolidated interim financial statements and related management discussion and analysis for the three and nine months ended December 31, 2016.

During the first nine months of fiscal 2017, Plaintree realized revenues of $12,438,180 up from $11,030,756 for the same period of fiscal 2016 with net losses of $(1,039,870) and $(2,058,347) in the respective periods. The notes to the financial statements and Management Discussion and Analysis for the period ended December 31, 2016 contain comments from management regarding the ability of Plaintree to continue as a going concern as discussed in Section 2(d) of the notes to the financial statements and the section entitled “Outlook – Going Concern” in the Management Discussion and Analysis.

For more information on these results, please refer to Plaintree’s annual 2016 financial statements together with the related Management’s Discussion and Analysis report, copies of which can be obtained from the Company’s website at www.plaintree.com and/or under Plaintree’s name at www.sedar.com.

About Plaintree Systems

Plaintree has two diversified product lines consisting of Specialty Structures and Electronics.

The Specialty Structures Division includes the former Triodetic Group with over 40 years of experience, is a design/build manufacturer of steel, aluminum and stainless steel specialty structures such as commercial domes, free form structures, barrel vaults, space frames and industrial dome coverings, Arnprior Fire Trucks Corp., a manufacturer of high end fire and emergency vehicles, Spotton Corporation, a design and manufacturer of high end custom hydraulic and pneumatic valves and cylinders and the recently acquired Madawaska Doors, a design and manufacturer of premium solid wood doors.

The Electronics Division includes the legacy Hypernetics, Summit Aerospace USA Inc. and Plaintree free space optics (FSO) businesses. Plaintree’s FSO systems transmit data at high speeds using beams of light instead of traditional radio frequency which can suffer from congestion. Hypernetics was established in 1972 and is a manufacturer of avionic components for various applications including aircraft antiskid braking, aircraft instrument indicators, solenoids, high purity valves and permanent magnet alternators. Summit Aerospace USA Inc. provides high precision machining to the aerospace and defense markets. Our facility includes 5 axis CNC precision machining of complex castings and large ring parts such as turbine and assembly shrouds as well as assembly & pressure seals. Summit will support requirements from concept, prototype and throughout production.

Plaintree’s shares are traded under the symbol “NPT”. Shareholders and Investors can access Company information on CSE’s website and receive full Company disclosure monthly. For more information on Plaintree or to receive stock quotes, complete with trading summaries, bid size and ask price, brokerage house participation, insider reports, news releases, disclosure information, and CSE and SEDAR filings, visit the CSE website at www.cnsx.ca or the Company’s website at www.plaintree.com.

Plaintree is publicly traded in Canada on the CSE (NPT) with 12,925,253 common shares and 18,325 class A preferred shares outstanding.

This press release may include statements that are forward-looking and based on current expectations. The actual results of the company may differ materially from current expectations. The business of the company is subject to many risks and uncertainties, including changes in markets for the company’s products, delays in product development and introduction to manufacturing and intense competition. For a more detailed discussion of the risks and uncertainties related to the company’s business, please refer to documents filed by the company with the Canadian regulatory authorities, including the annual report of the Company for the fiscal year ended March 31, 2016 and related management discussion and analysis.

Canadian Securities Exchange has not reviewed and does not accept responsibility for the adequacy or accuracy of the content of this news release.

For further information: (613) 623-3434 x2261

SOURCE: Plaintree Systems Inc.

ReleaseID: 455967

American CuMo Provides Notice of Default to Platinum Resources International Limited Regarding Poly Resources LLC Agreement

VANCOUVER, BC / ACCESSWIRE / February 24, 2017 / American CuMo Mining Corporation (TSX-V: MLY) (OTC PINK: MLYCF) (“CuMoCo” or the “Company”) announces that Platinum Resources International Limited (“PRI”) did not contribute the sum of US$10,000,000 as required within 90 days of the effective date of the Limited Liability Agreement of Poly Resources LLC (“Poly”) with the Company’s wholly-owned subsidiary, Idaho CuMo Mining Corporation (“Idaho CuMo”).

As such, Idaho CuMo has provided written notice to PRI of such failure to contribute the US$10,000,000, and as a result, PRI is deemed to have resigned as a member of Poly and has lost its right to earn an interest in Poly, which holds an option to purchase the Calida Mine gold property in Idaho and the right to purchase up to 20% of Idaho CuMo’s shares (please refer to the Company’s news release of November 21, 2016). Idaho CuMo remains the sole member of Poly.

PRI had requested an extension of the due date for the payment of the US$10,000,000 and had also proposed alternative financing terms, but CuMoCo’s management and Board of Directors decided not to proceed further with the intended financing transaction with PRI. Instead, the Company has engaged in discussions and negotiations with another third party with a view to entering a strategic financial relationship with such third party. The Company expects to announce such alternative financing transaction shortly.

About CuMoCo

CuMoCo is focused on advancing its CuMo Project towards feasibility and establishing itself as one of the largest and lowest-cost molybdenum producers in the world as well as a significant producer of copper and silver. CuMoCo also intends to advance its newly-acquired Calida Gold Project. Management is continuing to build an even stronger foundation from which to move the Company and its projects forward. For more information, please visit www.cumoco.com , www.idahocumo.com and www.cumoproject.com.

For further information, please contact:

American CuMo Mining Corporation
Shaun Dykes, President and Chief Executive Officer
Tel: (604) 689-7902
Email: info@cumoco.com

Neither the TSX Venture Exchange nor its Regulation Service Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this new release.

Forward-looking information

This news release contains “forward-looking information” within the meaning of applicable Canadian securities legislation including, but not limited to, statements that address activities, events or developments that the Company expects or anticipates will or may occur in the future, such the Company’s ability to move its CuMo Project to feasibility and production, and to become one of the largest and lowest-cost molybdenum producers in the world as well as a significant producer of copper and silver. Forward-looking information is based on a number of material factors and assumptions, including the result of exploration activities, the ability of the Company to raise the financing for a feasibility study and to put the CuMo project into production, that no labour shortages or delays are experienced, that plant and equipment function as specified that the Court will not intervene with the Company’s proposed exploration activities at the CuMo Project, and the ability of the Company to obtain all requisite permits and licenses to advance the CuMo Project and eventually bring it into production. Forward-looking information involves known and unknown risks, future events, conditions, uncertainties and other factors which may cause the actual results, performance or achievements to be materially different from any future prediction, projection or forecast expressed or implied by the forward-looking information. Such factors include, among others, the interpretation and actual results of current exploration activities; changes in project parameters as plans continue to be refined; future prices of molybdenum, silver and copper; possible variations in grade or recovery rates; labour disputes and other risks of the mining industry; delays in obtaining governmental approvals or financing, as well as those factors disclosed in the Company’s publicly filed documents, including the Company’s Management’s Discussion and Analysis for the period ended September 30, 2016. There may be other factors that cause actions, events or results not to be as anticipated, estimated or intended. There can be no assurance that forward-looking information will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking information. Except as required under applicable securities legislation, the Company undertakes no obligation to publicly update or revise forward-looking information.

SOURCE: American CuMo Mining Corporation

ReleaseID: 455971

Global Micro Bioreactors Market is Expected to Grow at a CAGR of 9.68%. by 2022

ReportsWeb.com added “Global Micro Bioreactors Market Research Report 2017” to its vast collection of research Database. The report is spread across 120 pages and supported by 10 company leaders.

February 24, 2017 /MarketersMedia/

In the reporting year, the sales Revenue of Micro Bioreactors increases from 177.51 M USD in 2012 to 256.84 M USD in 2016, with a CAGR of more than 9.68%.

In the Europe, the region contributing the highest share of sales revenue of slightly more than 26% in 2016, despite stagnant macroeconomic environment in this region in the reporting year. The Emerging developing countries represented by China has Witnessed high rates increase in the reporting year, the sales revenue of China increases from 20.11 M USD in 2012 to 37.53 M USD in 2016, with an CAGR of more than 16.88%. However, high cost of instruments, lack of research and development of technology especially in emerging economies, and lack of laboratory technicians are expected to restrain the growth of this market.

The Global Micro Bioreactors Market Research Report 2017 is a professional and in-depth study on the current state of the Micro Bioreactors industry. In a word, This report studies Micro Bioreactors in Global market, especially in North America, China, Europe, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with capacity, production, price, revenue and market share for each manufacturer. Key companies included in this research are Pall Corporation , Sartorius, Eppendorf, M2p-labs, Applikon Biotechnology, Chemtrix, CerCell, INFORS HT, LAVAL LAB and PBS Biotech.

Browse complete report @ http://www.reportsweb.com/global-micro-bioreactors-market-2017

Market Segment by Region, this report splits Global into several key Region, with sales, revenue, market share and growth rate of Micro Bioreactors in these regions, from 2011 to 2022 (forecast), like United States, North America, China, Europe, Japan, Southeast Asia and India. Firstly, Micro Bioreactors Market Split by Product Types, with production, revenue, price, market share and growth rate of each type, can be divided into 24 Parallel Bioreactors, 48 Parallel Bioreactors and Others. Split by applications, this report focuses on consumption, market share and growth rate of Micro Bioreactors in each application, can be divided into Pharma, Biotech, Food Industry, Scientific Research Institutes and Others.

Request for Sample @ http://www.reportsweb.com/inquiry&RW0001637224/sample

Major points from Table of Contents:

1 Micro Bioreactors Market Overview

2 Global Micro Bioreactors Market Competition by Manufacturers

3 Global Micro Bioreactors Production, Revenue (Value) by Region (2011-2017)

4 Global Micro Bioreactors Supply (Production) , Consumption, Export, Import by Regions (2011-2017)

5 Global Micro Bioreactors Production, Revenue (Value) , Price Trend by Type

6 Global Micro Bioreactors Market Analysis by Application

7 Global Micro Bioreactors Manufacturers Profiles/Analysis 48

7.1 Pall Corporation 48
7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 48
7.1.2 Micro Bioreactors Product Types, Application and Specification 49
7.1.3 Pall Corporation Micro Bioreactors Production, Revenue, Gross and Price (2015 and 2016) 51
7.1.4 Main Business/Business Overview 51
7.2 Sartorius 52
7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 52
7.2.2 Micro Bioreactors Product Types, Application and Specification 53
7.2.3 Sartorius Micro Bioreactors Production, Revenue, Gross and Price (2015 and 2016) 54
7.2.4 Main Business/Business Overview 55
7.3 Eppendorf 55
7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 55
7.3.2 Micro Bioreactors Product Types, Application and Specification 56
7.3.3 Eppendorf Micro Bioreactors Production, Revenue, Gross and Price (2015 and 2016) 57
7.3.4 Main Business/Business Overview 58

8 Micro Bioreactors Manufacturing Cost Analysis

9 Industrial Chain, Sourcing Strategy and Downstream Buyers

10 Marketing Strategy Analysis, Distributors/Traders

11 Market Effect Factors Analysis

12 Global Micro Bioreactors Market Forecast (2017-2022)

13 Research Findings and Conclusion

List of Tables and Figures

Table Europe Micro Bioreactors Production, Revenue, Price and Gross Margin (2012-2017E) 33
Table China Micro Bioreactors Production, Revenue, Price and Gross Margin (2012-2017E) 33
Table Japan Micro Bioreactors Production, Revenue, Price and Gross Margin (2012-2017E) 34
Table Southeast Asia Micro Bioreactors Production, Revenue, Price and Gross Margin (2012-2017E) 34
Table India Micro Bioreactors Production, Revenue, Price and Gross Margin (2012-2017E) 35
Table Global Micro Bioreactors Consumption (Unit) Market by Regions (2012-2017E) 36
Table Global Micro Bioreactors Consumption Market Share by Regions (2012-2017E) 36
Figure Global Micro Bioreactors Consumption Market Share by Regions (2012-2017E) 37
Figure 2015 Global Micro Bioreactors Consumption Market Share by Regions 37
Table USA Micro Bioreactors Production, Consumption, Import & Export (2012-2017E) 38
Table Europe Micro Bioreactors Production, Consumption, Import & Export (2012-2017E) 38
Table China Micro Bioreactors Production, Consumption, Import & Export (2012-2017E) 38
Table Japan Micro Bioreactors Production, Consumption, Import & Export (2012-2017E) 39
Table Southeast Asia Micro Bioreactors Production, Consumption, Import & Export (2012-2017E) 39
Table India Micro Bioreactors Production, Consumption, Import & Export (2012-2017E) 39
Table Global Micro Bioreactors Production (Unit) by Types (2012-2017E) 40
Table Global Micro Bioreactors Production Share by Types (2012-2017E) 40
Figure Production Market Share of Micro Bioreactors by Types (2012-2017E) 41
Figure 2016 Production Market Share of Micro Bioreactors by Types 41
Table Global Micro Bioreactors Revenue (M USD) by Types (2012-2017E) 42
Table Global Micro Bioreactors Revenue Share by Types (2012-2017E) 42
Figure Production Revenue Share of Micro Bioreactors by Types (2012-2017E) 42
Figure 2016 Revenue Market Share of Micro Bioreactors by Types 43
Table Global Micro Bioreactors Price (K USD/Units) by Types (2012-2017E) 43
Figure Global Micro Bioreactors Production Growth by Type (2012-2017E) 44
Table Global Micro Bioreactors Consumption (Unit) by Applications (2012-2017E) 45
Table Global Micro Bioreactors Consumption Market Share by Applications (2012-2017E) 45
Figure Global Micro Bioreactors Consumption Market Share by Applications in 2015 46
Table Global Micro Bioreactors Consumption Growth Rate by Applications (2012-2017E) 46

Place a Direct Purchase Order of Complete Report @ http://www.reportsweb.com/buy&RW0001637224/buy/2900

Contact Info:
Name: Sameer Joshi
Email: sales@reportsweb.com
Organization: ReportsWeb
Address: Pune, India.
Phone: +1-646-491-9876

Source URL: http://marketersmedia.com/global-micro-bioreactors-market-is-expected-to-grow-at-a-cagr-of-9-68-by-2022/172855

For more information, please visit http://www.reportsweb.com/global-micro-bioreactors-market-2017

Source: MarketersMedia

Release ID: 172855